Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Asianet Newsable on MSN
Reliance's Strand Life Sciences patents blood test for early cancer
Reliance's Strand Life Sciences has been granted an Indian patent for its platform enabling early cancer detection from a ...
PreOncology today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology ...
Hyderabad: A class XII student from Hyderabad, Ansh Kumar, has developed an artificial intelligence (AI)-assisted model for ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Dognosis, a startup in Bengaluru, is using AI, motion sensor and dog treats to create a multi-cancer detection test.
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
The patented platform combines high-quality genome sequencing, rigorous quality control, biologically informed methylation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results